FIELD: medicine.
SUBSTANCE: invention refers to new compounds of formula (I) and their pharmaceutically acceptable salts, which inter alia inhibit hepatotropic hepatitis C virus and are applicable in treating hepatitis C virus. In formula (I) R1 is specified in a group consisting of
is specified in a group consisting of a carbon-carbon single bond and carbon-carbon double bond; R5, R6, R11, R12, R13 and R14 are independently specified in a group consisting of a hydrogen atom, methyl and a protective group for nitrogen specified in C1-6alkylsulphonyl; R7 represents a hydrogen atom; R2 is specified in a group consisting of a halogen atom, C1-6alkyl and heterocyclyl specified in 5-merous heteroaryl with 1-2 heteroatoms specified in nitrogen, oxygen and sulphur, wherein alkyl is optionally substituted by one or more substitute optionally specified in a group consisting of a halogen atom; and heterocyclyl is optionally substituted by C1-3alkyl; R3 is specified in a group consisting of C1-6alkyl, C2-4alkenyl, C1-6alkyloxy and a halogen atom; L means a bond, and R4 is specified in a group consisting of C5-C6-carbocyclyl, or R4 means carbocyclyl with 2 condensed cycles specified in a group consisting of naphthalinyl, indenyl and dihydroindenyl, hexahydroindenyl, octahydroindenyl, wherein each can be substituted by a substitute specified in a group consisting of RE, RF and RJ, and RE means hydroxy, oxo; RF means C1-3alkyl substituted by C1-4alkylsulphonylamino, imino, wherein imino is substituted by a C1-4alkylsulphonylamino group; and RJ means an alkylsulphonylamino group; or L is specified in a group consisting of C(RA) = C(RB), wherein RA and RB mean a hydrogen atom, and R4 is specified in a group consisting of C6carbocyclyl specified in phenyl substituted by RJ having the above value.
EFFECT: higher efficacy of the compound.
16 cl, 2 tbl, 52 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL COMPOUNDS AND THEIR APPLICATION | 2010 |
|
RU2552533C2 |
N-PHENYL-DIOXOX-HYDROPYRIMIDINE USED AS HEPATITIS C VIRUS INHIBITOR (HCV) | 2008 |
|
RU2542099C2 |
URACYL AND THYMINE DERIVATIVES FOR TREATING HEPATITIS C | 2008 |
|
RU2543620C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505540C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505539C2 |
URACIL OR THYMINE DERIVATIVES FOR TREATING HEPATITIS C | 2013 |
|
RU2599635C2 |
ANTIVIRAL COMPOUNDS | 2010 |
|
RU2541571C2 |
ANTIVIRAL COMPOUND | 2006 |
|
RU2441010C2 |
NITROGEN-CONTAINING TRICYCLIC DERIVATIVES HAVING HIV REPLICATION INHIBITION ACTIVITY | 2016 |
|
RU2720145C2 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
Authors
Dates
2015-12-20—Published
2010-03-25—Filed